Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.

Vogl TJ, Langenbach MC, Hammerstingl R, Albrecht MH, Chatterjee AR, Gruber-Rouh T

Open source

DOI
10.1007/s12072-021-10193-8
Published
2021 Jun
Container
Hepatology international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12072-021-10193-8,
  title = {Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.},
  author = {Vogl TJ and Langenbach MC and Hammerstingl R and Albrecht MH and Chatterjee AR and Gruber-Rouh T},
  year = {2021},
  journal = {Hepatology international},
  doi = {10.1007/s12072-021-10193-8},
  url = {https://doi.org/10.1007/s12072-021-10193-8}
}

RIS

TY  - JOUR
TI  - Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.
AU  - Vogl TJ
AU  - Langenbach MC
AU  - Hammerstingl R
AU  - Albrecht MH
AU  - Chatterjee AR
AU  - Gruber-Rouh T
PY  - 2021
JO  - Hepatology international
DO  - 10.1007/s12072-021-10193-8
UR  - https://doi.org/10.1007/s12072-021-10193-8
ER  - 

APA

TJ, V., MC, L., R, H., MH, A., AR, C., & T, G. (2021). Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.. Hepatology international. https://doi.org/10.1007/s12072-021-10193-8

Source records